Tags: Drug.
Girentuximab (trade name Rencarex) is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.Girentuximab was developed by Wilex AG.
Loading...
This page contains content from the copyrighted Wikipedia article "Girentuximab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.